课题基金 / 基金详情

Phase II, proof-of-concept randomized controlled trial to evaluate dental caries preventive effects of fluoridated bottle water

Phase II, proof-of-concept randomized controlled trial to evaluate dental caries preventive effects of fluoridated bottle water
第二阶段,概念验证随机对照试验,评估氟化瓶装水的龋齿预防效果
批准号:
10458235
负责人:
Gary Douglas Slade
金额:
$104.92万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-17 至 2026-09-16

项目摘要

项目成果

Gary Douglas Slade的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Dental health benefits of fluoride in drinking water have never been tested in a randomized controlled trial (RCT). Instead, results from observational studies and a few non-randomized, community intervention studies were sufficient to justify addition of fluoride to many public water systems during the 20th century and to defend against fluoridation’s critics. However, growth in fluoridated public water systems has stalled, leaving 100 million Americans living in places that do not have fluoridated water and which probably never will. A related problem is that, nationwide, 15% of children do not drink tap water for reasons ranging from consumer preference to distrust of public water. One solution, capitalizing on consumers’ demand for bottled water, is to increase consumption of fluoridated bottled water. However, RCT evidence of dental health benefits of fluoridated bottled water will be essential if public health is to embrace it as a strategy to extend fluoridation. In the absence of a precedent, and in the face of uncertainty as to compliance and likely effect size of the intervention, a fully powered RCT is premature. We instead propose a phase II, proof-of-concept RCT to evaluate dental caries preventive effects of fluoridated bottled water in a community not served by water fluoridation. The primary recruitment population is ~470 babies born during a one-year period in Kinston, NC, the state’s community with the largest non-fluoridated public water system where caries prevalence exceeds the state average. In households where measured content of fluoride in tap water is <0.2 ppm, we will randomize 200 infant/family dyads in a 1:1 ratio to receive either fluoridated or non-fluoridated bottled water. The two types of commercially water in 5-gallon bottles will be relabeled to mask infants, families and researchers as to the fluoride content. For 3½ years after randomization, each household will be provided with water, dispensers and other supplies to encourage water consumption consistent with nutritional recommendations. Bottled water consumption will be monitored and fingernail clippings collected to provide a biomarker-measure of fluoride intake. A dental examination conducted when children are aged 48?3 months will measure caries experience using the index of decayed, missing and filled tooth surfaces (dmfs). Statistical analysis will compare mean dmfs between study-groups to generate effect size estimates and standard errors needed to calculate sample size requirement for a future, multi-site, Phase III RCT. The investigative team has a strong record of accomplishment in observational and interventional studies of dental caries in children, and is experienced in work needed to plan (during the UG3 phase) and conduct (during the 5-year UH3 phase) the study as required by PAR-18-547. Local, state and national stakeholders have expressed support for the proposed study, noting its potential to improve oral health in underserved communities. By applying the rigor of a placebo-controlled RCT design, the study will address a serious shortfall in the evidence that hampers the nation’s primary public health strategy for dental caries prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase II, proof-of-concept randomized controlled trial to evaluate dental caries preventive effects of fluoridated bottle water
  • 批准号:
    10472070
  • 项目类别:
  • 资助金额:
    $106.48万
  • 财政年份:
    2021
  • 负责人:
    Gary Douglas Slade
  • 依托单位:
Is Periodontal Disease Involved in the Etiology of Non-Alcoholic Fatty Liver Disease
Is Periodontal Disease Involved in the Etiology of Non-Alcoholic Fatty Liver Disease
Effects of cumulative stress and change in pain regulation on risk of chronic TMD
国内基金
海外基金
基于生境成像与深度学习联合临床特征构建II型卵巢癌术前淋巴结转移预测模型的研究
鸡软骨非变性II型胶原高效制备和靶向递送的关键技术开发与应用示范
青蒿琥酯协同TROP2/线粒体级联靶向的NIR-II多模态诊疗用于晚期TNBC精准诊断与治疗的机制研究
  • 批准号:
    2026JJ30126
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    杨沙
  • 依托单位:
苏合颗粒治疗慢性萎缩性胃炎的临床(II期)评价关键技术研究